GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » Shares Buyback Ratio %

ReNeuron Group (ReNeuron Group) Shares Buyback Ratio % : -0.05 (As of Apr. 26, 2024)


View and export this data going back to 2006. Start your Free Trial

What is ReNeuron Group Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. ReNeuron Group's current shares buyback ratio was -0.05%.

ReNeuron Group Shares Buyback Ratio % Historical Data

The historical data trend for ReNeuron Group's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Shares Buyback Ratio % Chart

ReNeuron Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.59 -73.90 -0.37 -0.19

ReNeuron Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.14 -0.22 -0.14 -0.05 -

ReNeuron Group Shares Buyback Ratio % Calculation

ReNeuron Group's Shares Buyback Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Mar. 2022 ) - Shares Outstanding (EOP) (A: Mar. 2023 )) / Shares Outstanding (EOP) (A: Mar. 2022 )
=(57.0636 - 57.1738) / 57.0636
=-0.19%

ReNeuron Group's Shares Buyback Ratio for the quarter that ended in Sep. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Mar. 2023 ) - Shares Outstanding (EOP) (A: Sep. 2023 )) / Shares Outstanding (EOP) (A: Mar. 2023 )
=(57.1738 - 57.1738) / 57.1738
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ReNeuron Group Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

ReNeuron Group (ReNeuron Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » Shares Buyback Ratio %
Comparable Companies
LSE:PYC LSE:NFX LSE:EVG LSE:APTA LSE:FAB LSE:IXI LSE:GENF LSE:OCTP LSE:VAL AQSE:INC OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX
Traded in Other Exchanges
RENE.GB:UK RENE:UK RQE1:Germany
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
Website
https://www.reneuron.com
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.